SPARC announces results from interim analysis PROSEEK of Vodobatinib in PD
09 Apr 2024 //
PHARMABIZ
PROSEEK study shows no treatment benefit of Vodobatinib Parkinson’s Disease
09 Apr 2024 //
EXPRESS PHARMA
09 Apr 2024 //
PHARMABIZ
09 Apr 2024 //
EXPRESS PHARMA